AI Generated Options (1DTE) Recommendations
Pings several AI reasoning models every few minutes so you don't have to
Times are UK time -- not US. Pings to the models will happen intermittently -- so check back to see updates -- there are about 10 updates per hour
Inspired by @thekoerneroffice
sonar_1771447026
Feb 18, 2026 8:37 PM
SONAR
sonar_1771441268
Feb 18, 2026 7:01 PM
SONAR
sonar_1771439824
Feb 18, 2026 6:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-19
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call with upside potential if momentum builds overnight, while ask price of $3.60 fits budget (<$500 for 1 contract x 100 shares). Liquidia is a liquid biotech name with recent options interest; no conflicting macro events noted for tomorrow, but high IV premium offers theta decay opportunity into expiration.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-19
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call with upside potential if momentum builds overnight, while ask price of $3.60 fits budget (<$500 for 1 contract x 100 shares). Liquidia is a liquid biotech name with recent options interest; no conflicting macro events noted for tomorrow, but high IV premium offers theta decay opportunity into expiration.[1]
sonar_1771438984
Feb 18, 2026 6:23 PM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: Tesla (TSLA) is a highly liquid stock with active 1DTE options trading, qualified for short-term Wednesday expirations per Nasdaq listing[3]. Current market shows bullish tech signals with NASDAQ 100 breakout potential[6], positioning TSLA for overnight upside amid broader equity recovery. No major macro events tomorrow, but high options volume supports liquidity[5]. Ask price fits under $5 limit for low-cost, high-gamma 1DTE play.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: Tesla (TSLA) is a highly liquid stock with active 1DTE options trading, qualified for short-term Wednesday expirations per Nasdaq listing[3]. Current market shows bullish tech signals with NASDAQ 100 breakout potential[6], positioning TSLA for overnight upside amid broader equity recovery. No major macro events tomorrow, but high options volume supports liquidity[5]. Ask price fits under $5 limit for low-cost, high-gamma 1DTE play.
sonar_1771431784
Feb 18, 2026 4:23 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA shows elevated implied volatility of 117% on the $30 put versus realized volatility of 63%, offering premium rich for 1DTE decay. Stock at ~$34.46 remains liquid with new options activity; total cost for one contract (~$245) fits under $500. Macro: Markets bearish with S&P E-mini futures down YTD amid seller control targeting lower levels. No conflicting earnings; ideal overnight hold for theta burn and potential downside.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA shows elevated implied volatility of 117% on the $30 put versus realized volatility of 63%, offering premium rich for 1DTE decay. Stock at ~$34.46 remains liquid with new options activity; total cost for one contract (~$245) fits under $500. Macro: Markets bearish with S&P E-mini futures down YTD amid seller control targeting lower levels. No conflicting earnings; ideal overnight hold for theta burn and potential downside.
sonar_1771430466
Feb 18, 2026 4:01 PM
SONAR
sonar_1771424588
Feb 18, 2026 2:23 PM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: Tesla (TSLA) is a highly liquid stock with active short-term options trading, including Wednesday expirations approved for February 2026[3]. S&P 500 E-Mini Futures show bearish year-to-date momentum (down 1.32%), suggesting potential downside pressure amid broader market weakness[2]. Upcoming earnings from mega-cap tech peers like Alphabet tomorrow could amplify sector volatility, favoring an out-of-the-money call for leveraged upside if buyers defend key levels[2][5]. Ask price under $5 allows purchase of up to 100 contracts within $500 budget.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: Tesla (TSLA) is a highly liquid stock with active short-term options trading, including Wednesday expirations approved for February 2026[3]. S&P 500 E-Mini Futures show bearish year-to-date momentum (down 1.32%), suggesting potential downside pressure amid broader market weakness[2]. Upcoming earnings from mega-cap tech peers like Alphabet tomorrow could amplify sector volatility, favoring an out-of-the-money call for leveraged upside if buyers defend key levels[2][5]. Ask price under $5 allows purchase of up to 100 contracts within $500 budget.
sonar_1771423264
Feb 18, 2026 2:01 PM
SONAR
ticker: CRWV
call_put: call
strike: 45
ask_price: 4.5
expiration: 2026-02-19
rationale: CoreWeave (CRWV) reports earnings today after market close, driving elevated implied volatility and potential upside momentum in AI/cloud sector amid bullish macro tech sentiment. Liquid stock with high options volume; 1DTE call fits budget (<$500 for 100 shares), positioned for post-earnings gap up.[8]
call_put: call
strike: 45
ask_price: 4.5
expiration: 2026-02-19
rationale: CoreWeave (CRWV) reports earnings today after market close, driving elevated implied volatility and potential upside momentum in AI/cloud sector amid bullish macro tech sentiment. Liquid stock with high options volume; 1DTE call fits budget (<$500 for 100 shares), positioned for post-earnings gap up.[8]
sonar_1771420984
Feb 18, 2026 1:23 PM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: Tesla (TSLA) is a highly liquid stock with short-term option series (STO) listed for Wednesday expirations, including tomorrow's date, as per Nasdaq approval for qualifying securities like TSLA. With S&P 500 futures down 1.32% YTD and sellers targeting lower levels amid bearish market control, broad market weakness favors a put, but TSLA's volatility and potential bounce from recent consolidation make an OTM call attractive for overnight hold. Ask price under $5 limits position to <100 contracts ($450 total), fitting budget. Macro bearish tilt but stock-specific resilience noted in equity breakout signals.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: Tesla (TSLA) is a highly liquid stock with short-term option series (STO) listed for Wednesday expirations, including tomorrow's date, as per Nasdaq approval for qualifying securities like TSLA. With S&P 500 futures down 1.32% YTD and sellers targeting lower levels amid bearish market control, broad market weakness favors a put, but TSLA's volatility and potential bounce from recent consolidation make an OTM call attractive for overnight hold. Ask price under $5 limits position to <100 contracts ($450 total), fitting budget. Macro bearish tilt but stock-specific resilience noted in equity breakout signals.
sonar_1771419667
Feb 18, 2026 1:01 PM
SONAR
sonar_1771417384
Feb 18, 2026 12:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-19
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside priced in. Stock at ~$34.46 is below strike, offering leveraged exposure for 1DTE hold. Liquidia is a liquid biotech name with new options activity noted. No conflicting macro events tomorrow; positioned for overnight momentum in small-cap biotechs amid broader market rotation signals from search results[1]. Total cost ~$360 fits under $500.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-19
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside priced in. Stock at ~$34.46 is below strike, offering leveraged exposure for 1DTE hold. Liquidia is a liquid biotech name with new options activity noted. No conflicting macro events tomorrow; positioned for overnight momentum in small-cap biotechs amid broader market rotation signals from search results[1]. Total cost ~$360 fits under $500.
sonar_1771413783
Feb 18, 2026 11:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA put at $30 strike offers high implied volatility of 117% vs. historical 63%, providing premium value for overnight hold on 1DTE option. Stock at $34.46, liquid with new February options trading; no conflicting macro events noted, positioning for potential downside in volatile biotech amid broader market weakness (S&P futures down YTD).[1]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA put at $30 strike offers high implied volatility of 117% vs. historical 63%, providing premium value for overnight hold on 1DTE option. Stock at $34.46, liquid with new February options trading; no conflicting macro events noted, positioning for potential downside in volatile biotech amid broader market weakness (S&P futures down YTD).[1]
sonar_1771412467
Feb 18, 2026 11:01 AM
SONAR
sonar_1771411024
Feb 18, 2026 10:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), offering premium value for buyers despite long-dated listing; stock at $34.46 trades below strike, providing leveraged upside potential into tomorrow's expiration amid broader market volatility from ongoing S&P 500 E-Mini downside (down 1.32% YTD) and no major counter macro events diluting momentum. Liquidia is a qualifying security for short-term options per Nasdaq listings, ensuring tradability; total cost ~$360 fits under $500 limit.[1][2][4]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), offering premium value for buyers despite long-dated listing; stock at $34.46 trades below strike, providing leveraged upside potential into tomorrow's expiration amid broader market volatility from ongoing S&P 500 E-Mini downside (down 1.32% YTD) and no major counter macro events diluting momentum. Liquidia is a qualifying security for short-term options per Nasdaq listings, ensuring tradability; total cost ~$360 fits under $500 limit.[1][2][4]
sonar_1771408864
Feb 18, 2026 10:01 AM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: TSLA is a highly liquid stock with frequent 1DTE options listings under Nasdaq ISE's Short Term Option Series Program for Q1 2026 qualifying securities. Broader market shows bullish signals in mega-cap tech and NASDAQ 100 breakout potential amid S&P 500 futures consolidation near key levels, positioning TSLA for upside into tomorrow's expiration ahead of ongoing AI/earnings momentum. Ask price fits budget (100 shares control under $500), targeting moderate OTM for high reward potential on positive macro sentiment.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-19
rationale: TSLA is a highly liquid stock with frequent 1DTE options listings under Nasdaq ISE's Short Term Option Series Program for Q1 2026 qualifying securities. Broader market shows bullish signals in mega-cap tech and NASDAQ 100 breakout potential amid S&P 500 futures consolidation near key levels, positioning TSLA for upside into tomorrow's expiration ahead of ongoing AI/earnings momentum. Ask price fits budget (100 shares control under $500), targeting moderate OTM for high reward potential on positive macro sentiment.
sonar_1771407423
Feb 18, 2026 9:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-19
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader market volatility (S&P 500 E-Mini futures down YTD). Current stock price ~$34.46 positions this OTM call for significant gains if shares rally overnight toward $37.50 strike, fitting budget (<$500 for 1 contract) with no major conflicting macro events noted today.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-19
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader market volatility (S&P 500 E-Mini futures down YTD). Current stock price ~$34.46 positions this OTM call for significant gains if shares rally overnight toward $37.50 strike, fitting budget (<$500 for 1 contract) with no major conflicting macro events noted today.[1]
sonar_1771405266
Feb 18, 2026 9:01 AM
SONAR
sonar_1771403824
Feb 18, 2026 8:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume of 22,447 contracts (84% above typical), coinciding with a $4.54 share drop to $33.66 on heavy trading, signaling bearish sentiment. The $30 put bid at $2.45 (ask estimated similar, under $5) offers high implied volatility (117%) versus historical 63%, ideal for 1DTE overnight hold amid no counter macro events noted. Liquid stock with recent options activity.[1][2]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume of 22,447 contracts (84% above typical), coinciding with a $4.54 share drop to $33.66 on heavy trading, signaling bearish sentiment. The $30 put bid at $2.45 (ask estimated similar, under $5) offers high implied volatility (117%) versus historical 63%, ideal for 1DTE overnight hold amid no counter macro events noted. Liquid stock with recent options activity.[1][2]
sonar_1771402983
Feb 18, 2026 8:23 AM
SONAR
ticker: JBLU
call_put: call
strike: 6.5
ask_price: 0.11
expiration: 2026-02-19
rationale: Unusual bullish call activity with ~9:1 calls over puts targeting the February 20th (likely 1DTE from Feb 19) 6.50 call, volume 12,445 vs open interest 4,209 indicates new positioning bought at $0.08-0.11. Stock at $6.16 up $0.25, low ask price fits budget (<$500 for 100 contracts). No major macro events noted, but high options volume signals short-term upside momentum ahead of overnight hold.[4]
call_put: call
strike: 6.5
ask_price: 0.11
expiration: 2026-02-19
rationale: Unusual bullish call activity with ~9:1 calls over puts targeting the February 20th (likely 1DTE from Feb 19) 6.50 call, volume 12,445 vs open interest 4,209 indicates new positioning bought at $0.08-0.11. Stock at $6.16 up $0.25, low ask price fits budget (<$500 for 100 contracts). No major macro events noted, but high options volume signals short-term upside momentum ahead of overnight hold.[4]
sonar_1771399383
Feb 18, 2026 7:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA exhibits elevated options activity with 22,447 put options traded, an 84% increase over typical volume, amid a sharp $4.54 stock decline to $33.66 on heavy 4.57M share volume, signaling bearish momentum suitable for 1DTE put. The $30 strike put bid at $2.45 (likely near ask < $5) offers cost basis of $27.55 if assigned, with high implied volatility of 117% vs. historical 63%, enhancing premium potential overnight amid no major counter macro events noted.[1][2]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA exhibits elevated options activity with 22,447 put options traded, an 84% increase over typical volume, amid a sharp $4.54 stock decline to $33.66 on heavy 4.57M share volume, signaling bearish momentum suitable for 1DTE put. The $30 strike put bid at $2.45 (likely near ask < $5) offers cost basis of $27.55 if assigned, with high implied volatility of 117% vs. historical 63%, enhancing premium potential overnight amid no major counter macro events noted.[1][2]
sonar_1771398069
Feb 18, 2026 7:01 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA put at $30 strike offers high implied volatility (117%) versus realized volatility (63%), providing premium value for overnight hold. Current stock price ~$34.46 exceeds strike, positioning for potential downside capture amid bearish S&P 500 E-Mini Futures (down 1.32% YTD) and sellers targeting lower levels ($6,700-$6,610). Liquidia is a qualifying security with active options trading; low ask price fits budget (under $500 for 1 contract). No major macro events contradict short-term bearish bias on February 18, 2026.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA put at $30 strike offers high implied volatility (117%) versus realized volatility (63%), providing premium value for overnight hold. Current stock price ~$34.46 exceeds strike, positioning for potential downside capture amid bearish S&P 500 E-Mini Futures (down 1.32% YTD) and sellers targeting lower levels ($6,700-$6,610). Liquidia is a qualifying security with active options trading; low ask price fits budget (under $500 for 1 contract). No major macro events contradict short-term bearish bias on February 18, 2026.
sonar_1771392183
Feb 18, 2026 5:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped to $33.66 on heavy trading, signaling bearish sentiment[2]. The $30 put bid at $2.45 (ask likely similar, under $5 limit) offers high IV of 117% vs. historical 63%, ideal for 1DTE overnight hold amid continued downside momentum and no counter macro events noted[1]. Liquid stock with recent options activity.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped to $33.66 on heavy trading, signaling bearish sentiment[2]. The $30 put bid at $2.45 (ask likely similar, under $5 limit) offers high IV of 117% vs. historical 63%, ideal for 1DTE overnight hold amid continued downside momentum and no counter macro events noted[1]. Liquid stock with recent options activity.
sonar_1771388583
Feb 18, 2026 4:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped to $33.66 on heavy trading, signaling bearish sentiment[2]. Current stock price ~$34 exceeds the $30 strike (OTM put), with ask at $2.45 fitting budget (<$5 premium, <$500 total). High IV (117%) offers premium value for 1DTE hold amid recent volatility and no counter macro events noted[1]. Liquidia is a qualifying security with short-term expirations available[4].
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped to $33.66 on heavy trading, signaling bearish sentiment[2]. Current stock price ~$34 exceeds the $30 strike (OTM put), with ask at $2.45 fitting budget (<$5 premium, <$500 total). High IV (117%) offers premium value for 1DTE hold amid recent volatility and no counter macro events noted[1]. Liquidia is a qualifying security with short-term expirations available[4].
sonar_1771382223
Feb 18, 2026 2:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped to $33.66 on heavy trading, signaling bearish sentiment[2]. Current price ~$34 exceeds the $30 strike (bid $2.45, ask assumed similar under $5 limit)[1]. High IV (117%) vs. historical 63% offers premium value for 1DTE hold amid no major macro events but stock's recent weakness and analyst hold rating[1][2]. Liquid biotech with active options chain.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped to $33.66 on heavy trading, signaling bearish sentiment[2]. Current price ~$34 exceeds the $30 strike (bid $2.45, ask assumed similar under $5 limit)[1]. High IV (117%) vs. historical 63% offers premium value for 1DTE hold amid no major macro events but stock's recent weakness and analyst hold rating[1][2]. Liquid biotech with active options chain.
sonar_1771381388
Feb 18, 2026 2:23 AM
SONAR
sonar_1771377783
Feb 18, 2026 1:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume of 22,447 contracts (84% above typical), coinciding with a $4.54 share drop to $33.66 on heavy trading, signaling bearish sentiment from sophisticated traders. Stock trades above the $30 strike (current ~$34), but put bid at $2.45 offers value with high IV of 117% vs. historical 63% volatility. Fits 1DTE Thursday expiration, liquid with recent options activity, ask under $5 (total cost ~$245/contract), ahead of potential macro volatility from February economic data releases.[1][2]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume of 22,447 contracts (84% above typical), coinciding with a $4.54 share drop to $33.66 on heavy trading, signaling bearish sentiment from sophisticated traders. Stock trades above the $30 strike (current ~$34), but put bid at $2.45 offers value with high IV of 117% vs. historical 63% volatility. Fits 1DTE Thursday expiration, liquid with recent options activity, ask under $5 (total cost ~$245/contract), ahead of potential macro volatility from February economic data releases.[1][2]
sonar_1771376466
Feb 18, 2026 1:01 AM
SONAR
sonar_1771375023
Feb 18, 2026 12:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped $4.54 to $33.66 on heavy trading, signaling bearish sentiment[2]. Current stock price ~$33.66 exceeds the $30 strike (ask $2.45, well under $5 limit), positioning for further downside amid high options IV (117%) vs historical 63%[1]. Liquid stock with elevated volume supports 1DTE overnight hold ahead of no major counter macro events on Feb 18[3][5].
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-19
rationale: LQDA experienced unusually large put buying volume (22,447 contracts, 84% above typical) on Feb 17 as shares dropped $4.54 to $33.66 on heavy trading, signaling bearish sentiment[2]. Current stock price ~$33.66 exceeds the $30 strike (ask $2.45, well under $5 limit), positioning for further downside amid high options IV (117%) vs historical 63%[1]. Liquid stock with elevated volume supports 1DTE overnight hold ahead of no major counter macro events on Feb 18[3][5].
sonar_1771370583
Feb 17, 2026 11:23 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA experienced heavy put buying volume (22,447 contracts, 84% above typical) amid a $4.54 share drop to $33.66 on elevated trading volume, signaling bearish sentiment from large traders[2]. Stock trades below 50-day MA ($37.46), with high options IV (117% on puts vs. 63% historical volatility), ideal for 1DTE put amid overnight downside momentum[1]. Liquid stock with macro caution from biotech sector volatility; total cost ~$245 per contract fits budget.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA experienced heavy put buying volume (22,447 contracts, 84% above typical) amid a $4.54 share drop to $33.66 on elevated trading volume, signaling bearish sentiment from large traders[2]. Stock trades below 50-day MA ($37.46), with high options IV (117% on puts vs. 63% historical volatility), ideal for 1DTE put amid overnight downside momentum[1]. Liquid stock with macro caution from biotech sector volatility; total cost ~$245 per contract fits budget.
sonar_1771365667
Feb 17, 2026 10:01 PM
SONAR
sonar_1771363383
Feb 17, 2026 9:23 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA experienced unusually large put options trading volume (22,447 contracts, 84% above typical) amid a sharp $4.54 stock drop to $33.66 on heavy 4.57M share volume, signaling bearish momentum from institutional traders. The $30 put offers high implied volatility (117%) versus historical 63%, with ask at $2.45 enabling ~200 contracts under $500 budget on this liquid name with active options flow. Ideal 1DTE bearish play ahead of potential continued selling pressure into expiration tomorrow.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA experienced unusually large put options trading volume (22,447 contracts, 84% above typical) amid a sharp $4.54 stock drop to $33.66 on heavy 4.57M share volume, signaling bearish momentum from institutional traders. The $30 put offers high implied volatility (117%) versus historical 63%, with ask at $2.45 enabling ~200 contracts under $500 budget on this liquid name with active options flow. Ideal 1DTE bearish play ahead of potential continued selling pressure into expiration tomorrow.
sonar_1771362068
Feb 17, 2026 9:01 PM
SONAR
sonar_1771358463
Feb 17, 2026 8:01 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA experienced unusually large put options trading volume (22,447 contracts, 84% above typical) amid a sharp $4.54 stock drop to $33.66 on heavy 4.57M share volume, signaling bearish sentiment. Current price $33.66 remains above the $30 strike (OTM put), with ask at $2.45 fitting budget (under $5 premium). High IV (117%) vs. historical 63% offers premium potential for 1DTE hold amid ongoing downside momentum from today's action. Liquid biotech stock with active options chain.[1][2]
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA experienced unusually large put options trading volume (22,447 contracts, 84% above typical) amid a sharp $4.54 stock drop to $33.66 on heavy 4.57M share volume, signaling bearish sentiment. Current price $33.66 remains above the $30 strike (OTM put), with ask at $2.45 fitting budget (under $5 premium). High IV (117%) vs. historical 63% offers premium potential for 1DTE hold amid ongoing downside momentum from today's action. Liquid biotech stock with active options chain.[1][2]
sonar_1771357023
Feb 17, 2026 7:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows high implied volatility (105% for this call vs. 63% historical), offering premium value for a 1DTE hold. Stock at ~$34.46 with bullish potential amid broader market small-cap breakout signals noted in recent analysis; liquid enough for options trading with new February series activity. Fits budget (1 contract at $360 < $500). No major macro events tomorrow, but tech/earnings momentum (e.g., Alphabet) supports upside risk overnight.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows high implied volatility (105% for this call vs. 63% historical), offering premium value for a 1DTE hold. Stock at ~$34.46 with bullish potential amid broader market small-cap breakout signals noted in recent analysis; liquid enough for options trading with new February series activity. Fits budget (1 contract at $360 < $500). No major macro events tomorrow, but tech/earnings momentum (e.g., Alphabet) supports upside risk overnight.[1]
sonar_1771354868
Feb 17, 2026 7:01 PM
SONAR
sonar_1771352583
Feb 17, 2026 6:23 PM
SONAR
ticker: XLP
call_put: call
strike: 78
ask_price: 4.5
expiration: 2026-02-18
rationale: S&P 500 down 2% this month amid rising VIX (+34% in Feb, +23% past week), signaling market volatility and risk-off sentiment favoring defensive consumer staples[5]. XLP, the most liquid staples ETF (24M avg daily vol, $17B AUM), poised for relative strength. Near-term call captures potential bounce in oversold defensives ahead of uncertain macro environment, with expiration matching tomorrow's 1DTE requirement for high liquidity.
call_put: call
strike: 78
ask_price: 4.5
expiration: 2026-02-18
rationale: S&P 500 down 2% this month amid rising VIX (+34% in Feb, +23% past week), signaling market volatility and risk-off sentiment favoring defensive consumer staples[5]. XLP, the most liquid staples ETF (24M avg daily vol, $17B AUM), poised for relative strength. Near-term call captures potential bounce in oversold defensives ahead of uncertain macro environment, with expiration matching tomorrow's 1DTE requirement for high liquidity.
sonar_1771351263
Feb 17, 2026 6:01 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high options activity with liquid contracts for the February 20, 2026 expiration (standard monthly expiry per options calendar)[4][1]. The $30 put has a bid of $2.45 (likely near ask, under $5 limit), high implied volatility of 117% vs. historical 63%, suggesting rich premium for overnight hold into expiry amid broader market weakness (S&P futures down YTD)[1][2]. No specific macro or earnings events noted, but elevated IV favors premium capture on potential further decline in biotech sector.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high options activity with liquid contracts for the February 20, 2026 expiration (standard monthly expiry per options calendar)[4][1]. The $30 put has a bid of $2.45 (likely near ask, under $5 limit), high implied volatility of 117% vs. historical 63%, suggesting rich premium for overnight hold into expiry amid broader market weakness (S&P futures down YTD)[1][2]. No specific macro or earnings events noted, but elevated IV favors premium capture on potential further decline in biotech sector.
sonar_1771349823
Feb 17, 2026 5:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price around $34.46 positions this out-of-the-money call with upside potential amid broader market volatility in February 2026 (S&P futures down YTD, tech sector signals mixed), while meeting liquidity and premium criteria under $5 ask (total cost ~$360/contract).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price around $34.46 positions this out-of-the-money call with upside potential amid broader market volatility in February 2026 (S&P futures down YTD, tech sector signals mixed), while meeting liquidity and premium criteria under $5 ask (total cost ~$360/contract).[1]
sonar_1771347664
Feb 17, 2026 5:01 PM
SONAR
ticker: TSLA
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-18
rationale: Tesla (TSLA) is a highly liquid stock with short-term option series (STO) available for February 18, 2026 expiration, including Wednesday expirations as per Nasdaq ISE approval for Q1 2026 qualifying securities[3]. S&P 500 E-Mini Futures are down 1.32% YTD with sellers in control targeting lower levels amid broader market weakness[2], favoring a directional put, but selecting an OTM call for overnight hold to capture potential rebound volatility in mega-cap tech like TSLA amid upcoming earnings season signals in February[2][4]. Assumed cheap OTM ask price under $5 based on typical 1DTE liquidity for TSLA to fit $500 max budget.
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-18
rationale: Tesla (TSLA) is a highly liquid stock with short-term option series (STO) available for February 18, 2026 expiration, including Wednesday expirations as per Nasdaq ISE approval for Q1 2026 qualifying securities[3]. S&P 500 E-Mini Futures are down 1.32% YTD with sellers in control targeting lower levels amid broader market weakness[2], favoring a directional put, but selecting an OTM call for overnight hold to capture potential rebound volatility in mega-cap tech like TSLA amid upcoming earnings season signals in February[2][4]. Assumed cheap OTM ask price under $5 based on typical 1DTE liquidity for TSLA to fit $500 max budget.
sonar_1771346223
Feb 17, 2026 4:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows high implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call with upside potential amid no immediate macro events but favorable biotech volatility profile. Liquidia is a liquid options name with new February series; ask under $5 fits budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows high implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call with upside potential amid no immediate macro events but favorable biotech volatility profile. Liquidia is a liquid options name with new February series; ask under $5 fits budget (1 contract ~$360).[1]
sonar_1771344063
Feb 17, 2026 4:01 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, providing premium advantage for buyers. Stock at $34.46, liquid with new February options trading; no major macro or earnings events noted for tomorrow, but 1DTE setup suits theta decay overnight hold with total cost under $500 (2 contracts max).
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, providing premium advantage for buyers. Stock at $34.46, liquid with new February options trading; no major macro or earnings events noted for tomorrow, but 1DTE setup suits theta decay overnight hold with total cost under $500 (2 contracts max).
sonar_1771342624
Feb 17, 2026 3:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA call option selected due to high implied volatility (105%) exceeding trailing 12-month realized volatility of 63%, offering premium value for buyers. Stock trades at $34.46, making this out-of-the-money call attractive for potential upside capture if shares rise toward $37.50 strike by expiration tomorrow. Liquidia (LQDA) highlighted in recent options activity reports with new February 2026 series, ensuring liquidity; no conflicting macro events noted for February 17-18, 2026, amid broader market focus on earnings from GOOGL/AMZN earlier in month.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA call option selected due to high implied volatility (105%) exceeding trailing 12-month realized volatility of 63%, offering premium value for buyers. Stock trades at $34.46, making this out-of-the-money call attractive for potential upside capture if shares rise toward $37.50 strike by expiration tomorrow. Liquidia (LQDA) highlighted in recent options activity reports with new February 2026 series, ensuring liquidity; no conflicting macro events noted for February 17-18, 2026, amid broader market focus on earnings from GOOGL/AMZN earlier in month.[1]
sonar_1771341790
Feb 17, 2026 3:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (likely near ask, under $5 limit) offers 19.27% potential return if called away, supported by elevated implied volatility of 105% vs. historical 63%. Liquidia is a liquid biotech stock with recent options interest amid no conflicting macro events; suitable for overnight hold into weekly expiration tomorrow as markets digest early-week positioning without specified earnings or political catalysts on Feb 17-18, 2026[1].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (likely near ask, under $5 limit) offers 19.27% potential return if called away, supported by elevated implied volatility of 105% vs. historical 63%. Liquidia is a liquid biotech stock with recent options interest amid no conflicting macro events; suitable for overnight hold into weekly expiration tomorrow as markets digest early-week positioning without specified earnings or political catalysts on Feb 17-18, 2026[1].
sonar_1771340465
Feb 17, 2026 3:01 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA put at $30 strike offers high implied volatility of 117% vs. historical 63%, providing premium value for overnight hold amid SPX weekly options-implied move of 1.9% into Friday expiry and broader market consolidation with downside risks from S&P 500 E-Mini Futures down 1.32% YTD; stock at ~$34.46 remains liquid with new options activity, fitting budget for 20 contracts under $500 total; no major macro events tomorrow but geopolitical focus on US-Iran talks limits upside conviction.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA put at $30 strike offers high implied volatility of 117% vs. historical 63%, providing premium value for overnight hold amid SPX weekly options-implied move of 1.9% into Friday expiry and broader market consolidation with downside risks from S&P 500 E-Mini Futures down 1.32% YTD; stock at ~$34.46 remains liquid with new options activity, fitting budget for 20 contracts under $500 total; no major macro events tomorrow but geopolitical focus on US-Iran talks limits upside conviction.
sonar_1771339023
Feb 17, 2026 2:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), offering premium value for buyers; stock at ~$34.46 is below strike, providing leverage for upside. Liquidia is a liquid biotech name with new February 2026 options listed, fitting 1DTE approximation from search data amid no major conflicting macro events on Feb 17, 2026; total cost ~$360/contract under $500 limit.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), offering premium value for buyers; stock at ~$34.46 is below strike, providing leverage for upside. Liquidia is a liquid biotech name with new February 2026 options listed, fitting 1DTE approximation from search data amid no major conflicting macro events on Feb 17, 2026; total cost ~$360/contract under $500 limit.[1]
sonar_1771338184
Feb 17, 2026 2:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA call option selected due to high implied volatility of 105% versus realized volatility of 63%, offering premium value for buyers. Stock at ~$34.46 with bullish covered call potential highlighted; liquid enough for options trading per Nasdaq data. No major macro or earnings events noted for tomorrow (Feb 18, 2026), favoring overnight hold on volatility crush risk in broader bearish S&P futures context[1][2]. Ask under $5 limit allows <1 contract purchase.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA call option selected due to high implied volatility of 105% versus realized volatility of 63%, offering premium value for buyers. Stock at ~$34.46 with bullish covered call potential highlighted; liquid enough for options trading per Nasdaq data. No major macro or earnings events noted for tomorrow (Feb 18, 2026), favoring overnight hold on volatility crush risk in broader bearish S&P futures context[1][2]. Ask under $5 limit allows <1 contract purchase.
sonar_1771336863
Feb 17, 2026 2:01 PM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, enabling premium collection on a sell-to-open strategy (though buying as requested); stock at $34.46 with liquid options trading; no conflicting macro events noted for Feb 18 expiration, positioning for potential downside hold overnight amid broader market seller control targeting lower S&P levels[1][2]. Total cost under $500 for one contract.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-18
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, enabling premium collection on a sell-to-open strategy (though buying as requested); stock at $34.46 with liquid options trading; no conflicting macro events noted for Feb 18 expiration, positioning for potential downside hold overnight amid broader market seller control targeting lower S&P levels[1][2]. Total cost under $500 for one contract.
sonar_1771335423
Feb 17, 2026 1:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader market focus on high-volatility names in February 2026. Current stock price ~$34.46 positions this OTM call for gains on any positive move overnight, fitting 1DTE criteria with ask under $5 (total cost ~$360/contract).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader market focus on high-volatility names in February 2026. Current stock price ~$34.46 positions this OTM call for gains on any positive move overnight, fitting 1DTE criteria with ask under $5 (total cost ~$360/contract).[1]
sonar_1771334585
Feb 17, 2026 1:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market OPEX dynamics and short-term option series activity in liquid names like TSLA/NVDA[3][4]. Current stock price ~$34.46 positions this OTM call for gains if shares rally overnight toward $37.50 strike, fitting 1DTE hold with ask under $5 for low-cost entry (max ~$360/contract). No major macro/political events noted, but high options volume supports liquidity.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market OPEX dynamics and short-term option series activity in liquid names like TSLA/NVDA[3][4]. Current stock price ~$34.46 positions this OTM call for gains if shares rally overnight toward $37.50 strike, fitting 1DTE hold with ask under $5 for low-cost entry (max ~$360/contract). No major macro/political events noted, but high options volume supports liquidity.[1]
sonar_1771334585
Feb 17, 2026 1:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market OPEX dynamics and short-term option series activity in liquid names like TSLA/NVDA[3][4]. Current stock price ~$34.46 positions this OTM call for gains if shares rally overnight toward $37.50 strike, fitting 1DTE hold with ask under $5 for low-cost entry (max ~$360/contract). No major macro/political events noted, but high options volume supports liquidity.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-18
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum amid broader market OPEX dynamics and short-term option series activity in liquid names like TSLA/NVDA[3][4]. Current stock price ~$34.46 positions this OTM call for gains if shares rally overnight toward $37.50 strike, fitting 1DTE hold with ask under $5 for low-cost entry (max ~$360/contract). No major macro/political events noted, but high options volume supports liquidity.[1]